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ABSTRACT

The bacterial enzyme Methylthioadenosine/S-adenosylhomocysteine (MTA/SAH)
nucleosidase (MTN) is involved in methionine and adenine salvage from the by-products
of S-adenosylmethionine (SAM, AdoMet) dependent reactions. MTN plays a critical role
in alleviating product inhibition of SAM dependent reactions, including methylation
reactions and the synthesis of polyamines, vitamins, and autinducer signals. Due to its
absence from humans and its importance to bacterial metabolism, MTN is a potential
target for the development of novel antibiotics to treat microbial infections. In this study,
a MTN gene knock-out (MTN KO) strain of the pathogen E. coli O157:H7 was created to
study the impact of MTN activity on bacterial growth, virulence, and autoinducerdependent events; and to model the effects that would be expected from complete
pharmacologic interruption of enzyme activity. E. coli O157:H7 was chosen as the topic
of study since it is a serious gram-negative pathogen responsible for severe diarrhea that
can progress to cause hemolytic uremic syndrome (HUS), and factors influencing its
virulence are well known.
The MTN KO strain showed delayed growth, minimal biofilm production, and
decreased in vitro virulence when compared to the parental wild type (WT) strain.
Notably, the MTN KO strain showed a reduced ability to adhere to cultured mammalian
cells. An analysis of virulence factor expression showed that the MTN KO strain secreted
less Shiga-toxin, type-III secretory proteins, and hemolysin activity than the parental WT
strain. Culture supplementation with autoinducer-2 precursor, 4,5-dihydroxy-2,3vi

pentanedione (DPD) did not restore the growth or virulence of the MTN KO strain,
suggesting that the virulence defect was not the result of a loss of autoinducer-2
signaling. However, culture supplementation with lipoate, thiamine and biotin partially
reconstituted the growth and virulence phenotypes of the KO strain to WT levels,
indicating that altered vitamin-dependent metabolic activity played a role in the defect.
The lipoate- and thiamine-dependent enzymes in the pyruvate dehydrogenase complex
were overexpressed in the MTN KO strain, but the enzyme complex showed lower
specific activity than the WT strain, suggesting that the ability to synthesize these
vitamins was compromised in the KO strain. Other metabolic enzymes (lactate
dehydrogenase, alcohol dehydrogenase, glutamate dehydrogenase) were found to have
specific activities equal to the WT strain, thus providing release points for excess
metabolites in the KO strain.
This study provides support for MTN as a target for antibiotic treatment. Our
results indicate that one mechanism by which MTN specific inhibitors could exert their
antibiotic effect is by interrupting vitamin dependent processes, particularly in central
carbon metabolism. While loss of MTN activity was not bactericidal in this case, the
significant reduction in bacterial growth, biofilm formation and virulence suggests that
the bacteria treated with MTN inhibitors could have increased susceptibility to traditional
antibiotics and the host immune system responses. This supports the incorporation of
MTN inhibitors into combination drug therapies with standard antibiotics. Finally, the
creation and analysis of a MTN KO strain provides a valuable tool to explore potential
mechanisms of antibiotic action that can be used in comparative studies to examine the
antimicrobial activities of future MTN inhibitors.
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CHAPTER ONE: INTRODUCTION
The development of antibiotics in the 19th century revolutionized the field of
medicine by dramatically improving the ability to treat life-threatening infections. Paul
Erlich, who would become known as the “Father of Antibiotics,” first hypothesized that
if a dye was selectively toxic to bacterial cells, but not to mammalian cells, it would cure
all infections.1 After screening hundreds of dyes, Erlich discovered Salvarsan, the first
synthetic antibiotic used specifically to treat syphilis. In 1929, Sir Alexander Fleming
discovered that secreted products of the Penicillium mold could lyse Staphylococcus
cells, which marked the first report of the antibacterial action of a natural fungal product.2
Subsequently, the first widespread introduction of effective sulfonamides by
Domagk in 1937 was closely followed by reports of the development of bacterial
resistance.3 Resistance to sulfonamides, originally reported in the late 1930s, persists
today.2 Bacterial resistance to penicillin was also reported by two members of the
discovery team several years before its introduction as a therapeutic.4 Once penicillin was
widely distributed in the 1940s and 1950s, drug-resistant strains expressing penicillinase
(β-lactamase) activity became prevalent. To combat this, a widespread effort was made to
develop synthetic penicillinase inhibitors and new generations of penicillin-based drugs
that were resistant to earlier β lactamases.3 Invariably, the development and introduction
of every antibiotic has been followed by eventual bacterial resistance.
A more startling trend is that many bacterial pathogens associated with epidemics
of human disease have evolved multiple drug resistances.3 The evolution of drug
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resistance is encouraged by the misuse of antibiotics and the rapid adaptability of
bacteria. Hospitals serve as spawning grounds for many of these drug resistant strains.
The most prevalent example is methicillin-resistant Staphylococcus aureus (MRSA),
which developed resistance to methicillin only three years after the introduction of this
drug.3 With time, MRSA acquired multiple forms of drug resistance and developed into a
major community-acquired pathogen. Since then, a variety of other superbugs have
emerged, including carbenapem resistant Enterobacteriaceae (CRE). As standard forms
of antibiotics are becoming obsolete, there is a potential for all pathogenic bacteria to
resist antibiotic treatment. Thus, there exists a dire need for novel forms of antibiotics to
either replace or revitalize older drugs in order to prevent a reversion to the pre-antibiotic
age when every infection was potentially life threatening.
S-adenosylmethionine Reactions
S-adenosylmethionine (SAM) is an important nucleoside found in all living
organisms where it serves as an active group donor in a vast array of metabolic and
biosynthetic reactions.5 The main use of SAM is as the primary methyl group donor in
methylation reactions of macromolecules and small molecules. Other metabolic fates of
SAM include the synthesis of acylhomoserine lactones (autoinducer-1, AI-1), polyamine
synthesis (spermidine, spermine, etc), and radical SAM reactions involved in vitamin
synthesis (Figure 1). SAM is synthesized in the cytosol by methionine adenosyltransferase (MAT), which joins L-methionine to ATP and yields SAM, pyrophosphate
and phosphate ion (Figure 2).6 This transfer creates a metastable sulfonium ion, providing
a target for nucleophilic substitution reactions that allow the transfer of methyl-,
propylamino-, and other functional groups from SAM.
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Figure 1. S-adenosylmethionine metabolic reactions. SAM is used as a reagent in
transmethlyations, polyamine synthesis, autoinducer synthesis, and radical SAM reactions.
SAH, MTA, and 5‟dADO are toxic side products of these reactions. MTN is responsible for
the hydrolysis of the glycosidic linkage between the adenine and the ribose sugar. The ultimate
goal of these reactions is to allow salvage of both methionine and adenine.
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+

+
ATP

Methionine

+

SAM

Figure 2. Synthesis of SAM. SAM is synthesized in the cytosol by methionine
adenosyltransferase (MAT), which joins L-methionine to ATP and yields SAM,
pyrophosphate, and phosphate ion.
SAM-dependent methyltranferase reactions are diverse and critical for survival
(Figure 3). As an example, the methylation of cytosine in DNA regulates a variety of
mammalian gene activities, somatic inheritance, and cellular differentiation.7 In bacteria,
methylations are responsible for regulation of many processes, including motility, gene
expression, and the bacterial cell cycle.5 SAM is also the major methyl donor for
proteins, phospholipids, carbohydrates, and various other molecules. While a variety of
reaction mechanisms are used in transferases, the byproduct of the all the reactions is Sadenosylhomocystiene (SAH).5

+
SAM

+
SAH

Figure 3. SAM–dependent methyltransferase reaction. Generic representation of
SAM acting as a methyl donor. SAH can act as a product inhibitor to these reactions.
Polyamine and autoinducer syntheses are also SAM dependent and essential
molecules for cell growth and communication. The byproduct in each reaction is
methylthioadenosine (MTA). Spermidine is produced from the transfer of a 5‟
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propylamine group from decarboxylated SAM to putrescine by spermidine synthase
(Figure 4).5,11 Polyamines are fully protonated under physiological conditions and thus
carry a positive charge that form ionic interactions with negatively charged nucleic acids,
specific proteins, and phospholipids.11 It is known that the rate of DNA synthesis is
decreased by polyamine deficiency. Polyamines also confer protective effects against
apoptosis, and play a major role in protein synthesis.11

+

+
dcSAM

Putrescine

MTA

Spermidine

Figure 4. Polyamine synthesis. Spermidine synthase transfers the 5‟ propylamine group
from decarboxylated SAM to putrescine to produce spermidine. MTA acts as a product
inhibitor of this reaction.

N-acylhomoserine lactones (AI-1) are synthesized from the donation of an acyl
group from hexanoyl acyl carrier protein (ACP) to SAM.5 In this reaction, a cyclization
occurs to form the internal lactone ring and MTA as a byproduct (Figure 5).

+
SAM

+
Acyl-ACP

MTA

AI-1

Figure 5. Autoinducer-1 synthesis. AI-1 is synthesized from the donation of an acyl
group from hexanoyl ACP to SAM by LasI MTA can act as a product inhibitor to this
reaction.
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SAM is also used as an oxidizing agent in radical SAM dependent reactions. The
general reaction catalyzed by radical SAM enzymes occurs first by the reduction of the
sulfonium by a coordinated iron-sulfur cluster.9,10 The newly formed radical abstracts a
hydrogen from a substrate C-H bond (Figure 6).11 Products of this abstraction vary
greatly and include anaerobic oxidations, sulfur insertions, isomerizations, ring
formation, and unusual methylations.5 In addition to the formation of the desired product,
methionine and 5‟-deoxyadenosine (5‟-dADO) are formed as byproducts that can be
recycled back to form SAM.

+

+
SAM

Methionine 5‟-dADO
radical

+
5‟-dADO

Figure 6. Radical SAM reaction. Reduction of the sulfonium occurs through
coordination to an iron-sulfur cluster. The radical abstracts a hydrogen from a substrate
C-H bond. Methionine and 5‟-dADO are formed as byproducts. 5‟-dADO can act as a
product inhibitor to this reaction.
Radical SAM reactions are important to the synthesis of secondary metabolites,
vitamins, antibiotics, and assist with bacterial DNA repair. Biotin synthase is a radical
SAM enzyme that catalyzes the substitution of a bridging sulfur atom for hydrogen in
desthiobiotin to form the essential enzyme cofactor biotin.12 Lipoyl synthase is another
radical SAM enzyme that catalyzes the final step in de novo biosynthesis of the lipoate
cofactor by inserting two sulfur atoms into an 8-carbon-saturated fatty acyl chain.14
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Precursors of the cofactor thiamine are generated in several bacteria by the enzyme
tyrosine lyase, a radical SAM enzyme.13 Overall, the radical SAM super family is
currently composed of more than 2800 proteins involved in over 40 distinct biochemical
transformations.8
A regulatory characteristic of all of the above SAM dependent reactions is the
susceptibility to product inhibition by SAH, MTA, and 5‟-dADO.5 SAH has been shown
in vitro to inhibit a number of bacterial methyltransferases at low micromolar
concentrations.15,16 Several reports have also shown that enzymatic degradation of SAH
by MTA/SAH nucleosidase alleviates product inhibition of methylation reactions.17,18
The nucleoside MTA has also been shown to be a potent inhibitor of polyamine synthase
reactions at low micromolar concentrations.19-21 In addition, MTA inhibits 50% of
autoinducer-1 synthase activity at concentrations as low as 5 µM.21 Lastly, 5‟-dADO and
methionine were shown to inhibit biotin synthase, lipoyl synthase, and tyrosine lyase.10 In
order to reduce product inhibition by these nucleosides, all organisms have developed
efficient nucleosidases to catabolize them and salvage their constituent parts.
Methylthioadenosine/S-adenosylhomocystiene Nucleosidase and the
Methionine Salvage Pathway
Methythioadenosine/S-adenosylhomocysteine nucleosidase (MTN) catalyzes the
irreversible cleavage of MTA, SAH, and 5‟-dADO to adenine and the corresponding
pentose, 5-methylthioribose (MTR), S-ribosylhomocysteine (SRH), and 5-deoxy-Dribose (5-dRIB), respectively.5,22 MTN exists as a 25-35 kD homodimer and is found in
the methionine salvage pathway for the majority of bacteria (Figure 7).5,22,24 Specifically
in 51 bacterial species, including pathogens with reductive genomic evolution, MTN is

8
responsible for metabolism of the three nucleotides.23,25 Other bacteria that contain
relatively large genomes and exhibit complex metabolism use two enzymes to remove
MTA and SAH independently.26 These organisms behave metabolically more like
humans: a MTA phosphorylase converts MTA to 5-methythioribose-1-phosphate, while
SAH hydrolase catabolizes SAH.5 This more restricted substrate specificity is proposed
to allow more efficient metabolism to promote better survival in these organisms.27,28

Figure 7. Structure of the E. coli Methylthioadenosine/S-adenosylhomocysteine
Nucleosidase. Ribbon representation of the E. coli MTN dimer viewed down the
noncrystallographic two-fold axis. A molecule of the MTA analogue Formycin-A is
shown bound in each active site. (adapted from Lee et al., 2001)23

The ultimate purpose of MTN is to catabolize growth inhibitory MTA, SAH, and
5‟-dADO; and salvage the methionine and adenine, which are metabolically expensive to
synthesize.5 The adenine is recycled back to purine nucleosides. The thiopentoses MTR
and SRH require further enzymatic reactions to salvage the sulfur atom back into
methionine (Figure 8).5,29,30 The conversion of MTR to methionine begins with the
phosphorylation of MTR to MTR-1-phosphate (MTR-1-P) by MTR kinase.29 In bacteria
that contain a complete salvage pathway, an additional four or five enzymatic steps
(depending on the species) are required to convert MTR-1-P to methionine.5 Some
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organisms such as E. coli, that live in sulfur rich environments do not salvage methionine
and secrete MTR, instead.32

Figure 8. The methionine salvage pathway in bacteria. Dashed lines represent species
variations. (adapted from Sekowska et al., 2004).25
To salvage methionine from SAH catabolism, the majority of bacteria use the
enzyme LuxS to cleave the thiopentose S-ribosylhomocysteine (SRH) to produce
homocysteine and 4,5-dihydroxy-2,3-pentadione, the precursor to autoinducer-2 (AI-2,
Figure 9).5 Homocysteine is remethylated to form methionine using either cobalamindependent (MetH) or cobalamin-independent (MetE) methionine synthases.33,68
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SRH Homocysteine

DPD
AI-2
Figure 9. Autoinducer-2 synthesis. LuxS cleaves SRH to produce homocysteine and
4,5-dihydroxy-2,3-pentadione, which can then cyclize to form AI-2.
MTN is a potential novel antibiotic target due to its critical involvement in
microbial metabolism and its absence in humans. The first description of MTN enzyme
activity was reported in 1963.89 In 1979, a study of MTA analogs was published that
demonstrated that they were effective competitive inhibitors of MTN, and set the stage
for further exploration of this enzyme as a chemotherapeutic target.34 This initial
discovery lead to further studies on the development of substrate and transition-state
analogs.31,39,40 Extensive crystallographic studies revealed MTN exists as a homodimer
and established that enzyme-substrate interactions responsible for recognition and
catalysis.35-40 Importantly, these studies revealed that the active site of each subunit
contains a hydrophobic pocket involved in recognition of the 5‟ alkyl portion of the
nucleoside that is partially composed of residues from the second subunit.22,34-37 The
hydrolysis of the substrates is essentially irreversible and the acidic amino acid residues,
Glu12, Glu174, and Asp197, involved in catalysis are highly conserved across species.25,36,37
While substrates and transition states are similar between bacterial MTN and
mammalian MTA phosphorylase (MTP), crystallographic studies also reveal distinct
differences in the enzyme active sites. In MTN, the active site has a larger 5‟alkylthio
binding pocket, which allows for recognition of SAH and other larger thionucleoside
analogues than the active site of MTP.35 There are also surface charge differences in the
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region of the enzymes responsible for recognition of the 2‟hydroxyl-group on the
nucleoside: MTP is positively charged, while MTN is negatively charged.35 Combined,
these features suggest routes for directed drug design that would yield inhibitors capable
of discriminating between the two enzymes.5 The majority of the work to develop
specific selective inhibitors of MTN has been performed in Dr. Vern Schramm‟s lab at
Albert Einstein College.31,38-40,71 These inhibitors are based on transition state structures
for the substrate that would bind the enzyme active site with the highest affinity. Recent
specific potent late transition stage MTA analogs with bulky 5‟ substitutions (DADMeimmucillin 54: DADMe-immucillin 57) are selective inhibitors that bind with a thousandfold greater affinity (or more) to MTN than to MTP (Figure 10).38-40 However, most of
the studies testing MTN transition state inhibitors as antibiotics in E. coli and other
bacterial species have reported only modest activity, with IC50 values in the micromolar
range or higher.5 It has been proposed that the transition state analogs failed to exert
potent antibiotic effects due to poor drug permeability or transport into the cell.39
However, in species that are purine auxotrophs, such as Borrelia burgdorferi, MTN
inhibitors were more potent.40 Probably this is due to the greater need by these organisms
to salvage methionine and purines, which makes them more sensitive to MTN
interruption.40
Despite rather poor antibiotic effects in E. coli, MTN transition state analogues
have been shown to reduce AI-2 synthesis and biofilm formation.39 Thus, the inhibitors
have been proposed to act more as interrupters of microbial autoinducer signaling than as
direct bactericidal agents. This may be critically important since virulence, pathogenesis,
and drug resistance are thought to be regulated (at least partially) by intercellular
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communication. Interruption of bacterial communication represents a new paradigm for
the development of antibiotics. These drugs could act less directly than traditional
antibiotics (like penicillin) to kill bacteria. Instead, they could cause attenuation of the
pathogen so that the host immune system could more effectively combat the infection.
EARLY TRANSITION STATE ANALOGUES

MT-ImmA
Ki = 120 ± 5 pM

5’d-Et-ImmA
Ki = 130 ± 12 pM

LATE TRANSITION STATE ANALOGUES

MT-DADMe-ImmA
Ki = 86 pM

BuT-DADMe-ImmA
Ki = 296 fM

DADMe-ImmA 54
Ki = 64 pM

DADMe-ImmA 57
Ki = 54 pM

Figure 10. Early and late transition state analogues for MTN. Inhibitors of MTN
contain a non-hydrolyzable linkage between the adenine and pentose moieties. The
selectivity index for bacterial MTN can be up to a 1000 fold higher when compared
to human MTP. All Ki values reported are for E. coli MTN and were obtained from
the literature.31, 37-40, 71
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Quorum Sensing
Quorum sensing (QS) is the process of bacterial cell to cell communication that
involves production, detection, and response to extracellular signaling molecules known
as autoinducers (AI).45 QS was originally discovered over 30 years ago in two
bioluminescent bacterial species, Vibrio fischeri and Vibrio harveyi. In these species,
light emission occurred only at high cell population density, when the accumulation of
secreted AIs stimulated the expression of the structural operon luxCDABE, which
encodes the light producing luciferase enzyme.45 Since this initial discovery, it has been
reported that QS is responsible for an array of bacterial phenotypes and behaviors
including sporulation, competence, antibiotic production, biofilm formation, and
virulence factor secretion.45
While the regulatory components and molecular mechanisms of QS differ
between bacterial species, three basic principles apply. First, all communicating bacteria
produce AIs. When the population of a bacterial community is low, the AIs are in such
low concentration that they are unable to stimulate a population-wide response. After the
population reaches a high density, the additive amount of AIs produces a cumulative
response. The second principle of QS is that receptors for AIs exist in the membrane or
the cytoplasm of the responding cells. Lastly, AIs induce varied gene expression and
stimulate production of additional AIs through a positive feedback loop to sponsor
synchronous behavior in the cell population (Figure 11).45
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Figure 11. General scheme of a quorum sensing system. The signal synthase enzyme
produces signal molecules, which reach the extracellular environment via diffusion or
transport. At a critical signal molecule concentration, the signal binds to the receptor,
which can be located in the cytoplasm (A) or at the cell surface (B). If the receptor is
located in the cytoplasm, the signal-receptor complex activates or inactivates transcription
of target genes. If the receptor is located at the cell surface, the signal sets off a
phosphorylation signal transduction cascade that activates a transcriptional regulator at the
end modulate target gene transcription. (adapted from Defoirdt et al., 2010).97
The mechanism of QS differs in Gram-positive and Gram-negative bacteria. In
Gram-positive bacteria, small cyclic peptides (AIP) are used as signaling molecules while
in Gram-negative bacteria small molecules such as acyl-homoserine lactones are used
(Table 1). Staphylococcus aureus, a Gram-positive pathogen, utilizes AIPs to regulate the
agr system that controls over 70 genes. Many of these genes code for known virulence
factors.87 The first class of small molecule AIs (AI-1) is primarily used for intraspecies
communication in Gram-negative bacteria. AI-1 synthases use SAM as a substrate to
produce a variety of acylhomoserine lactones (Table 1), with MTA as a byproduct.
Pseudomonas aeruginosa utilizes AI-1 to regulate the production of several extracellular
virulence factors, promote biofilm maturation, and regulate the expression of antibiotic
efflux pumps.51
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Table 1. Bacterial Autoinducers
Autoinducer Type

Autoinducer Molecule

AI-1

AI-1

AI-2

AI-2

AI-3

Farnesol

AIP

The second class of small molecule AIs (AI-2) is considered a “universal”
signaling molecule that allows inter-species communication.46-48 AI-2 is produced by the
enzyme LuxS, which synthesizes 4,5-dihydroxy-2,3-pentanedione (DPD) that
spontaneously cyclizes into a pro-AI-2 structure (Figure 9).48,49 In marine environments
where boron is plentiful, pro-AI-2 spontaneously forms a boron diester structure (Table
1). 46,47,49 However, a large number of bacterial species synthesize and respond to AI-2 in
environments that may not contain boron, other derivatives of DPD exist. For some
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species, the formation of DPD is purely a byproduct of metabolism.47 AI-2 has been
shown to regulate biofilms and virulence factors in E. coli, as well as various other
species (Table 2).51, 76
Table 2. Autoinducer-2 Induced Effects
Phenotype
Biofilms

Bacterium
E. coli, Helicobacter pylori, Pseudomonas
gingivalis, Streptococcus gordonii,
Streptococcus mutans

Virulence Factors

Clostridium perfringens, E. coli,
Neisseria meningitidis,
Pseudomonas gingivalis,
Serratia marcescens,
Streptococcus pyogenes, Vibrio cholerae

Bioluminescence

Vibrio fischerii, Vibrio harveyi

There have been extensive investigations on the effects of luxS gene deletions,
due to its direct connection with quorum sensing. Neisseria meningitidis luxS knockout
strains were found to have reduced virulence.44 In other studies, luxS deficiency was
found to alter sporulation in Bacillus subtilis, hemolysin secretion in Listeria
monocytogenes, and twitching motility involved in colonization and biofilms in E. coli
and Salmonella.92
An expanding list of other autoinducers has also been described. This includes
autoinducer (AI-3), a molecule that is reported to have an epinephrine-like structure and
may allow the bacteria to respond to host signaling molecules. In E. coli 0157:H7, AI-3
appears to regulate the formation of attaching and effacing lesions.67,86 Lastly, microbial
intercellular communication is not confined to bacteria, the isoprenoid farnesol is
reported to act as an AI in the yeast Candida albicans.88
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Biofilms
In nature, the majority of bacteria are found within biofilms. Biofilms are
composed of communities of bacterial cells that attach and proliferate on living or
nonliving surfaces using a secreted extracellular polysaccharide matrix.53 This adhered
communal existence allows bacteria to occupy a favorable microenvironment rather than
simply being randomly dispersed. Thus, the traditional view of bacteria as existing solely
as planktonic or free-swimming cells has now been replaced by the idea that the
planktonic phase is simply a mechanism for translocation from one surface to another.52
Many persistent and chronic bacterial infections are attributed to formation of biofilms in
wound sites or on medical implants that resist antibiotic treatment and evade host
immune responses.54 In addition, bacterial biofilms on food processing equipment and
surfaces are a leading cause of food-borne illness.53
Biofilm formation is a sequential process (Figure 12). In the first phase, the
planktonic bacterial cells form a transient association with a new surface or to previously
adhered microbes. Upon finding a suitable location, the bacteria progress from a transient
association to form a microcolony. This colony may consist of one species or (more
commonly) a heterogenous mix of species. At this stage, the cell density reaches levels
that quorum sensing through AI molecules becomes feasible. The QS signaling pathways
lead to altered gene transcription that stimulates production of an exopolysaccharide
matrix that envelopes the micro-colony. Further alteration of gene transcription occurs to
adapt the individual bacterial cell to communal existence within the biofilm. The
modulation of biofilm unique genes includes the up-regulation of a wide array of
enzymes and transporters, such as adaptive surface enzymes used to metabolize the chitin
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from insects and crustaceans, and the creation of specialized nutrient transport channels
within the matrix.52,53 In multispecies biofilms, bacteria establish micro-communities
within the matrix that are optimized for both survival and symbiotic relationships
between the groups of bacteria.53 In essence, a biofilm is not a random assortment of
bacteria, but more akin to a developed city with defined architectures that allow a variety
of optimal microenvironments to exist.

Figure 12. Biofilm maturation is a complex developmental process involving five
stages. Stage 1: initial attachment; stage 2: irreversible attachment; stage 3: maturation I;
stage 4: maturation II; stage 5: dispersion. Each stage of development in the diagram is
paired with a photomicrograph of a developing P. aeruginosa biofilm. (adapted from
Monroe, 2007).84
Biofilms pose a major concern for the treatment of bacterial infections. The
extrapolysaccharide matrix provides a shield against bacteriophages and amoebae,
attenuates responses to antibiotics, and decreases access by the host immune system.54,55
The thickness of the biofilm matrix prevents antimicrobial agent penetration to the full
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depth required to eliminate all of the microbes, and hinders phagocytosis by host
neutrophils. Ultimately, this allows planktonic cells to escape and form other foci of
infection 54,55 Since traditional antibiotics work to both eradicate pathogens and support
host immune responses, these are much less effective in the context of biofilms.
Escherichia coli O157:H7
Enterohemorrhagic Escherichia coli O157:H7 is a pathogen often associated with
foodborne illness. Infection can lead to devastating or life-threatening systemic
manifestations such as hemolytic uremic syndrome (HUS) and hemorrhagic colitis
(HC).56 The main cause of these serious ailments originates from the release of bacterial
Shiga toxins (Stxs) during the infection, and subsequent damage to cells in the intestines,
kidneys, brain, and other organs.56 While other serogroups of E. coli also produce Stxs,
and are often more prevalent in humans, E. coli O157:H7 is especially virulent and
responsible for the majority of HUS cases worldwide.56,57
E. coli O157:H7 was first recognized in 1982 when an outbreak associated with
contaminated hamburger occurred in the Jack-in-the-Box restaurant chain in Oregon and
Michigan.58 Since then, sporadic outbreaks have occurred throughout the world. In 1998,
a particularly large outbreak occurred in Japan, when over 9,000 children were infected.59
Symptoms of infection begin with severe cramps, initially followed by watery and
then bloody diarrhea, with little or no fever.60 About 10% of cases develop into HUS,
which carries a mortality rate of 2-10%.57 The most susceptible to the development of
HUS are young children and the elderly.60
The three principal routes of transmission are: fecal-contaminated food and water,
person-to-person spread, and animal contact.60 The major animal carriers are healthy
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cattle, and to a lesser degree other domesticated ruminants like sheep and goats.56 These
animals act as reservoirs. E. coli O157:H7 is distributed through feces, which can
contaminate foods when manure is used as a fertilizer or by direct contact during the
slaughter and preparation of meat. Of these, contaminated meat, unpasteurized milk, and
fecal-contaminated fruit and vegetables are the most common vehicles of transmission.
However, undercooked ground beef is the major source of transmission accounting for 75
out of 183 reported foodborne outbreaks in the US between 1982 and 2002.57
The production of two antigenically distinct forms of Stx (Stx1 and Stx2) by E.
coli O157:H7 results in HUS and HC.61 Both toxins are compound toxins consisting of a
catalytic A subunit and a cell targeting pentameric B subunit. 56,57 After entering the cell
through receptor mediated endocytosis, the A subunit is proteolytically cleaved to yield
the catalytically active RNA N-glycosidase. This enzyme cleaves specific bonds in the
rRNA, preventing the binding of amino acyl-tRNA to the ribosome. This inhibits the
elongation of the peptide chain during peptide synthesis and eventually leads to cell death
(Figure 13).61 Ruminants lack the vascular Stx sensor, globotriaosylceramide. This allows
them to act as E. coli O157:H7 carriers unaffected by Stx toxicity.56
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Figure 13: Model for receptor mediated endocytic entry and processing of Shiga
toxin in a mammalian cell. Shiga toxin enters the cell by receptor-mediated
endocytosis. The B subunit of the toxin binds to the mammalian cell receptor
globotriaosylceramide (Gb3). The clathrin-coated pit is pinched off, and the coated
vesicle is formed. The vesicle is acidified, and may fuse with lysosomes. The A1
fragment within the cytosol binds the 60S ribosome, leading to inhibition of protein
synthesis and cell death. (adapted from O‟Brien et al., 1987).61

The ability of Stx to produce attaching and effacing (A/E) lesions on a variety of
cell types is one of the most important virulence characteristics found in E. coli O157:H7.
The A/E lesions can be described by degeneration and effacement of intestinal epithelial
cell microvilli, intimate adherence of bacteria to the epithelial cell surface and bacterial
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directed assembly of highly organized cytoskeletal structures in the host cells.57 These
organized cytoskeletal elements form pedestal-like structures beneath the adhered E. coli
O157:H7 cells and are a hallmark of this type of infection. Genetic studies have shown
that the genes responsible for A/E lesions map to a region that is designated the locus of
enterocyte effacement (LEE), and are considered a chromosomal pathogenicity island.66
LEE is composed of at least 41 different genes, all required for bacterial adherence to the
host cell.
The mechanism of adherence to host cells is very complex and a multitude of
factors play a role in the process. E. coli O157:H7, like many other Gram-negative
bacteria, has a type III protein secretion system (TTSS), which is a complex surface
structure used to deliver virulence proteins into the host cell (Figure 14).62,63 TTSS
consists of a needle-like flagella that pierces the host cell to inject proteins that modify
the membrane. The needle like flagella is comprised of multiple Escherichia secretion
proteins (Esp) with EspA forming a filamentous structure on the bacterial surface that
forms a bridge to the host cell; essentially the tip of the needle.64 EspB and EspD are
injected through the needle into the mammalian cell membrane, where they form the end
of the translocation complex required for other larger virulence factors to be injected
directly into the host cell cytoplasm.62, 63
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Figure 14: A schematic of type III secretion structures in E. coli O157:H7. Type
III secretion structures are composed of a needle-like complex (pink), which is
anchored in the bacterial cell wall and a translocation complex (blue) in the host
membrane. EspA (in green) extends from the tip of the needle and penetrates the host
mucous barrier and thick glycocalyx reaching the underlying intestinal enterocytes.
(adapted from He et al., 2004.)63

Adherence of E. coli O157:H7 to a mammalian cell is initiated by transfer of a
translocated intimin receptor (Tir) into the host cell. Tir, much like EspB, becomes part
of the mammalian cell membrane and provides a binding site for bacterial intimin. After
this binding occurs, Tir links host actin fibers to the membrane to form the characteristic
pedestal structure.65 This intimate binding allows other virulence factors to wreak havoc
on the host cell, eventually leading to A/E lesions.
The plasmid O157 (pO157) encodes for a myriad of additional virulence factors
not found in the chromosomal DNA.66 The first described virulence factor of pO157 was
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hemolysin, an endotoxin that lyses red blood cells by destroying their cell membrane
through phospholipase activity. While hemolysin is not essential for producing either
HUS or HC, the lysis of red blood cells provides iron for the pathogen that stimulates
growth and production of other toxins.57 Other virulence factors encoded on pO157 are
catalase-peroxidase, type II secretion proteins, serine protease, metalloprotease, and
putative adhesion genes.66
Virulence regulation in O157:H7 has been attributed to luxS mediated quorum
sensing (Table 3).23,67 The transcriptional regulation of genes in the LEE initiated through
quorum sensing is complex since it consists of two regulators and multiple gene operons
(Figure 15).75 The initial belief was that AI-2 controlled all aspects of virulence, but this
was later disproved when luxS mutants were still able to produce A/E lesions in cultured
epithelial cells.67

Table 3. Virulence factors affected by AI-2 in E. coli
Virulence Factor
Biofilm production
Motility
lee operons
qse transcription
Type III secretion
Generation time
Gene expression (404 genes)

Ref
52
86
80
79
80
86
86

Further investigation determined that the genes for TTSS were AI-3 dependent, a
signaling molecule that resembles epinephrine.67 Bacterial AI-3 receptors can also bind
host cell produced epinephrine, thus providing a link between mammalian and bacterial
communication pathways. It remains unclear whether the other aspects of virulence such
as toxin production and biofilm formation are AI-2 or AI-3 dependent.
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Figure 15. Model for luxS-dependent quorum sensing in enterohemorrhagic
(EHEC) and enteropathogenic (EPEC) Escherichia coli. Interactions limited to
EPEC are indicated by dashed lines. The histidine kinase QseC (quorum-sensing E.
coli regulator C), together with its cognate response regulator QseB, activates the
flagellar master operon flhDC (green boxes). Regulation of type III secretion (red
boxes) is mediated through QseA, and indirectly through Ler. Together, the two
proteins activate expression of five important lee operons that encode components of
the type III secretion apparatus as well as adhesion proteins (intimin, Eae), the
translocated intimin receptor (Tir), and other proteins. (adapted from Vendeville et
al., 2005.)76
Metabolomics and Proteomics of E. coli RK4353
In recent years, liquid chromatography-tandem mass spectrometry (LCMS) has
become an invaluable tool for the analysis of bacterial organisms. Extensive metabolic
and proteomic analysis have been performed on a plethora of bacterial species to
understand basic metabolism, and the changes to metabolism that occur in response to
drug treatment, gene deletion, and changes in environment.69 This knowledge can be used
to direct drug design by revealing new or additional targets.
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A pfs (MTN) gene knock-out strain was originally created in E. coli RK4353 to
investigate potential gene polarization effects that occurred when deleting the gene
encoding the periplasmic cobalamin-binding protein.68 While this Δpfs mutant was not
created for the purpose of analyzing MTN deficiency, it has provided a nonpathogenic
model system for these studies. A metabolite study of another nonpathogenic pfs knockout strain E. coli (MG1655) showed that it displayed up to 50% increases in SAM and
SAH concentrations.42 While these data are interesting, neither of these strains allow the
analysis of the effect of pfs gene deletion on virulence. However, these strains provide
tools for proteomic analysis of adaptations to MTN deficiency, such as additional enzyme
production or expression of enzymes used in potential alternate metabolic pathways.
As mentioned previously, SAM is involved in radical reactions that produce
vitamins that are required for enzymes to function properly. Inhibition of MTN would be
expected to cause accumulation of inhibitory levels of 5‟dADO that in turn act to
suppress the enzymes responsible for production of these vitamins. This is a possible
cause for the growth delays reported in various inhibition studies.40,41 Reduced vitamin
production can be analyzed by comparing the activity of enzymes found in central carbon
metabolism that require lipoate, thiamine, or biotin cofactors, such as the pyruvate
dehydrogenase and α-ketoglutarate dehydrogenase complexes, in the MTN KO strain to
the WT strain. The MTN KO strain could show differences in the activity of alternate
metabolic pathways, such as lactate dehydrogenase or alcohol dehydrogenase, that are
adapted due to MTN deficiency (Figure 16).
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Figure 16. Central carbon metabolism with highlighted aspects affected by
MTN deficiency. The specific enzymes or enzyme complexes of interest in this
study are noted in red. Essential enzyme cofactors directly related to SAM radical
reactions are highlighted in yellow.
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Summary
MTN is a critical enzyme required for bacterial metabolism and is a potential
target of novel antibiotics. Inhibition of MTN causes accumulation of potent feedback
inhibitory nucleosides that have significant effects on SAM metabolic pathways. The
effects range from the disruption of quorum sensing to the lack of methionine salvage.
While MTN inhibitors have shown limited bactericidal activity, they could be combined
with other treatments to enhance antibiotic responses or improve host immune system
removal of the bacterial infection.
To fully understand the complete effects of MTN inhibition, genetic knockouts
(MTN KO) of the pfs gene have been created in prior work.42,43 Removing the pfs gene
allows for the maximal level of MTN inhibition and provides a standard to validate MTN
as a drug target, and to use as a comparative tool to predict the effects of drug inhibition.
All of the MTN KO strains have shown growth deficiencies, probably due to the
inhibitory feedback effects of the nucleosides MTA, SAH, and 5‟dADO.5,42,43 Since
MTN activity is responsible for directly producing the S-ribosylhomocysteine precursor
for luxS dependent AI-2 synthesis, it is also probable that MTN deficiency will affect
quorum sensing dependent events proposed to be involved in biofilm formation and
virulence.
In the following chapters, the potential of MTN inhibition as a target for antibiotic
development have been investigated using a strain of pathogenic E. coli O157:H7. To
understand how complete drug inhibition of MTN would affect this pathogen, a genetic
knock-out of the pfs gene was created (MTN KO strain). The WT and MTN KO strains
were subject to a variety of analyses to establish the effects on growth, biofilm formation,
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and virulence. Supplementation studies (with vitamins and autoinducer-2) were designed
to explore the potential mechanisms of antibiotic action. Further investigations of
metabolic enzyme activity in central carbon metabolism involved the use of a nonpathogenic E. coli RK4353 MTN KO strain compared with its isogenic parental WT
strain. For these studies, a directed investigation was performed on various enzymes that
were predicted by proteomic data to be affected by MTN deficiency due to their
dependence on vitamins for activity. Overall, the MTN KO strain showed defects in
growth and virulence that appeared to be at least partially due to vitamin dependence.
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CHAPTER TWO: MATERIALS AND METHODS
Creation of Electrocompetent Cells
E. coli O157:H7 strain (ATCC 43894) was streaked for isolation on LB plates and
grown overnight at 37 °C. An isolated colony was used to inoculate 200 mL fresh LB
media. Cells were grown at 37 °C at 225 RPM until the culture optical density at 600 nm
(OD600) reached ~ 0.5. Cells were subsequently heat shocked for 10 minutes at 42 °C
with shaking, followed by 15 minutes on ice with rotation. Cells were harvested by
centrifuged at 8,000 xg for 15 minutes at 4 °C, and resuspended in 8 mL of ice cold 20%
glycerol. The culture was split into eight 2 mL centrifuge tubes and centrifuged at 10,000
xg for 1 minute. The supernatant was removed by aspiration, and the cell pellet washed
three times with ice cold 20% glycerol. Competent cell pellets were resuspended in 50 l
ice cold 20% glycerol and stored at -80°C.
Generation of MTN Knockout (MTN KO) Strain Using the λ-Red System
Deletion of the pfs gene was accomplished using the λ-red system.90 Briefly, the
recombinase encoding plasmid pKD46 was introduced into competent cells using
electroporation (2000 V, 200 Ω, and 25 μF). Following electroporation, samples were
recovered in SOC media and incubated at 37 °C with horizontal shaking for 1.5 hours.
Transformants were selected on LB plates supplemented with ampicillin (100 g/mL)
and chloramphenicol (25 g/mL) plates and grown overnight at 37 °C. An isolated
colony was selected and inoculated into 200 mL of fresh LB ampicillin (100 g/mL)

31
broth and grown at 37 °C until an OD600 of 0.1 was reached. Recombinase activity was
induced by the addition of arabinose to 10 mM, and continued incubation at 37 °C until
the culture reached an OD600 of 0.4. pKD46+ cells were made electrocompetent as
described above.
To create the MTN KO strain, the chloramphenicol resistance (Cmr) cassette in
pKD3 was amplified by polymerase chain reaction (PCR) using primers containing
flanking pfs homologous sequences: pfsLF-TTAGC CATGT GCCAG TTTCT GCACT
AGTGA CTCAA CCATC AGTGT AGGCT GGAGC TGCTT CG-3‟; pfsLR-ATGAA
AATCG GCATC ATTGG TGCAA TGGAA GAAGA AGTTA CGCTC ATATG AATAT
CCTCC TTA-3‟ (pfs sequences are italicized). The PCR reaction contained 20 ng pKD3
template, 50 pmol primer (each) and 1 unit One Taq Hot Start DNA polymerase (New
England BioLabs, Ipswich, MA). Cycling conditions consisted of 95 °C (7 min),
followed by 35 cycles of 94 °C (15 sec), 50 °C (30 sec), and 72 °C (90 sec). The 1.1 Kb
PCR product was purified using a Perfectprep® Gel Cleanup kit (Eppendorf, Hauppauge,
NY) and quantified by UV spectrophotometry. The purified chloramphenicol cassette
(100 ng) was introduced into competent E. coli O157:H7 cells containing pKD46 using
the conditions described above. Successful transformants were selected on LB agar plates
containing chloramphenicol (25 g/mL). The transformants (pfs, ampr, cmr) were cured
(25 g/mL), but lacking ampicillin. Loss of MTN activity in the E. coli 0157:H7 strain
(pfs, amps, cmr) was confirmed by enzyme assay and western blot analysis (see later
section).
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Generation of MTN Knock-In (MTN KI) Strain
A MTN KI strain was created from the E. coli O157:H7 MTN KO strain in order
to study the effect of gene reconstitution on the cellular phenotype. The E. coli O157:H7
(pfs, cmr) was made electrocompetent as described above. The plasmid pMTN29 was
introduced using the electroporation conditions described for pKD46 (above), and
positive transformants selected by growth on LB containing ampicillin (100 g/mL) and
chloramphenicol (25 g/mL).
Analysis of MTN Activity: Preparation of Bacterial Lysates
Fresh 5 mL cultures of E. coli O157:H7 WT, MTN KO, and MTN KI strains were
prepared in LB broth containing appropriate antibiotics and grown overnight at 37 °C
with shaking. Cultures were diluted into 100 mLs of fresh LB broth and re-incubated for
24 hours at 37 °C with shaking. Bacterial cells were harvested by centrifugation (5000 xg
/ 15 min) and resuspended in 1 mL PBS. Cells were lysed by sonication on ice using a
Misonix Sonicator 300 (power setting 7, 30 sec pulse, 1 min cooling, 2.5 min total
sonication). The lysates were centrifuged at 5,000 xg for 15 min at 4 °C to remove debris,
and the cell lysates transferred to fresh tubes. The protein concentration of the lysates was
determined using BioRad reagent (BioRad, Hercule, CA). Lysates were stored at -80 °C
until analyzed for MTN by immunoblot and enzyme assay.
Analysis of MTN Activity: Immunoblot Assay
The presence of MTN protein in the WT, MTN KO, and MTN KI strains was
analyzed by SDS-PAGE and western blot. Samples of cell lysate proteins (20 g/lane)
were electrophoresed (66 mA/45 min) on 15% acrylamide gels using a BioRad
Miniprotean system. An EZ-Run Prestained Rec Protein ladder (Thermo Fisher
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Scientific) was used as a standard to assess molecular weight. Separated proteins were
transferred to nitrocellulose by electroblotting at 10V for 18 hours. The blot was blocked
using 10x Superblock (Thermo Fisher Scientific) on a Millipore SNAP i.d. system. The
presence of MTN in the lysates was detected using a murine monoclonal anti-MTN
antibody26 (1:1000 dilution) and goat-anti-mouse Ig-HRP conjugate antibody (Thermo
Fisher Scientific). Blots were developed using Pierce ECL Western Blotting substrate and
Kodak X-Omat x-ray film.
Analysis of MTN Activity: Enzyme Assay
Activity of MTN in lysates of E. coli O157:H7 WT, MTN KO, and MTN KI
strains was determined by monitoring loss of absorbance at 275 nm accompanying the
cleavage of MTA into MTR and adenine using the extinction coefficient 1.6 mM-1 cm-1.31
The enzyme reactions contained 50 mM potassium phosphate (pH 7) and 100 µM MTA
in a final volume of 990 µL, and were initiated by the addition of 10 µL (40 g) of lysate.
The absorbance at 275 nm was measured using a Varian Cary 50 spectrophotometer.
Specific activities were calculated in U/mg (1U = 1 mol/min MTA degradation).
Cell Growth Assays
To determine the effect of MTN status on growth, fresh overnight cultures of E.
coli O157:H7 WT, MTN KO, and MTN KI strains were prepared in 5 mL Davis Minimal
Media (per liter: 7 g KH2PO4, 2 g K2HPO4, 1 g (NH4)2SO4, 0.5 g Na citrate 2H2O, 0.025
g MgSO4) supplemented with 0.2% glucose (DMMG). The overnight cultures were
diluted 1:10,000 and 200 µL used to inoculate triplicate wells in a 96-well plate. The
plate was incubated in a Synergy HT plate reader (BioTek, Winooski, VT) at 37 °C with
shaking, and absorbance readings at 600 nm were taken every 15 minutes for 72 hours.
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The assay was repeated with WT and KO strains with the DMMG medium supplemented
with either lipoate, thiamine, biotin, dihydroxypentane dione (DPD), or a mix of all four
supplements (1-100 µM).
Biofilm Assays
Cultures of the E. coli O157:H7 WT, MTN KO, and MTN KI strains were
established in the 96-well plates as described for the cell growth assays above. Cultures
were grown for 48 hours at 30 °C, which was optimal for biofilm formation. The media
was then removed and the wells washed three times with PBS (250 µL) to remove
loosely bound cells. Biofilms were fixed using 250 μL of a 1% paraformaldehyde
solution in PBS for 1 hour at 4 °C. Subsequently, wells were washed three times with
water, and the adhered biofilms stained with 250 L 0.1% crystal violet in PBS for 15
min.93 Plates were washed three to five times with water, and the bound crystal violet
solubilized in 250 L of an ethanol:acetone (80:20) solution for 15 min. Solubilized
material (200 L) was transferred to a fresh 96-well plate and an absorbance reading at
590 nm measured using a BioTek Synergy HT plate reader. The assay was repeated with
WT and KO strains grown in DMMG supplemented with DPD, a vitamin mix (1 M
each biotin, lipoate, thiamine), or DPD and a vitamin mix.
A second assay was performed to more readily visualize biofilm production.
Overnight cultures of the three strains were prepared as described above and diluted
(1:10,000) into 3 mL of fresh DMMG in a 5mL polystyrene culture tube. Cultures were
incubated for 48 hr at 30 °C. Biofilms were stained as describe above, with the
modification that the volumes for all washing, fixing, and staining steps were adjusted to
3.2 mL. Stained biofilms were photographed using a digital camera. The assay was
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repeated with WT and KO strains grown in DMMG media supplemented with either
DPD, vitamin mix, or DPD and vitamin mix as previously described.
The qualitative appearance of biofilms formed by the three strains was also
examined by confocal microscopy. Biofilms were grown on plastic coverslips partially
submerged in 5 mL cultures in DMMG media. Biofilms on coverslips were washed and
fixed as described above, but the volumes of solutions were adjusted to 5.5 mL for each
step. After the final wash, the coverslips were stained with 1 mL 0.1% (w/v) acridine
orange in PBS for 1 hour in the dark. Coverslips were rinsed lightly with PBS and the
biofilms visualized at 600x magnification using a Zeiss LSM Meta 510 confocal
microscope set to an excitation wavelength of 476 nm. Standard and Z-stack (20 slices)
images were analyzed using Zen 2012 digital imaging software (Carl Zeiss Microscopy,
Oberkochen, Germany).
Adherence Assays
The adherence of E. coli O157:H7 WT, MTN KO, and MTN KI strains to
mammalian epithelial cells was studied using a previously established protocol.94 Briefly,
bovine Mac-T epithelial cells were cultured in DMEM supplemented with 5% FBS,
penicillin (100 U/mg), and streptomycin (100 g/mL) at 37 °C with 5% CO2. When cells
were approximately 70% confluent, they were harvested and seeded in triplicate (~1 x
105 cells) onto coverslips in a 6-well plate. When cells on the coverslips were
approximately 70% confluent, the coverslips were washed with antibiotic-free DMEM
with 5% FBS. For adherence assays, E. coli O157:H7 WT, MTN KO, or MTN KI
cultures were grown overnight in LB broth at 37 °C with shaking, and diluted (1:10,000)
into DMEM. Cells were stained by addition of Syto-9 (10 g/mL) for 15 min, followed
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by three washes with DMEM. Infections were initiated by addition of 1 mL bacterial
cells (~1 x 106 cells) to the surface of the mammalian cells. Co-incubation of bacterial
and mammalian cells occurred for 3 hours at 37 °C with 5% CO2. The wells were then
washed with PBS and the cover slips fixed with 4% paraformaldehyde in PBS for 10 min
at room temperature. Coverslips were washed twice with PBS, permeabilized with 0.1%
Triton X-100 in PBS for 5 min, and non-specific binding sites blocked with 1% BSA in
PBS for 20 min. Cellular actin was stained with TRITC conjugated phalloidin dye (5
μg/mL in PBS) for 40 min. Coverslips were washed twice with PBS, dried, treated with
ProLong Gold antifade reagent (InVitrogen, Carlsbad, CA) and mounted on glass slides
with clear nail polish. Adherent bacterial cells were visualized at 1000x magnification
using a LSM Meta 510 confocal microscope with excitation wavelengths set to 348 nm
(DAPI), 476 nm (Syto-9), and 557 nm (TRITC). Images were analyzed using Zen 2012
digital imaging software (Carl Zeiss Microscopy, Oberkochen, Germany).
To quantify bacterial adherence, bovine Mac-T cells were prepared as described
above in a 6-well plate. Cultures were grown until they reached approximately 70%
confluence, and then infected with WT, MTN KO, or MTN KI strain cells grown
overnight in DMMG, DMMG supplemented with DPD (25 M), DMMG with vitamin
mix (100 µM each lipoate, biotin, and thiamine), or DMMG with DPD (25 M) and
vitamin mix (100 µM each). Co-incubation continued for 3 hours at 37 °C in 5% CO2
atmosphere. Subsequently, bacterial cultures were aspirated, the wells washed three times
with PBS, and the mammalian cells lysed by treatment with 0.1% Triton X-100 in PBS
for 15 min. Dilutions of detergent lysates were plated onto LB agar, incubated overnight
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at 37 °C, and the adhered cells enumerated by colony counting. Colony forming units
(CFU) were expressed as a percentage relative to the adhered WT CFU (set at 100%).
Vero Cell Cytotoxicity Assay
Shiga toxin production was measured using a Vero cell cytotoxicity assay,
essentially as described.85 To compare E. coli O157:H7 WT and MTN KO strain Shiga
toxin production, cells were cultured overnight at 37 °C with shaking in 2 mL DMMG
containing either: 1) no supplement; 2) 25 M DPD; 3) vitamin mix (100 M each
lipoate, biotin and thiamine); or 4) a mixture of DPD and vitamin mix. To prepare
secreted Shiga toxin samples, cultures were centrifuged at 15,000 xg for 5 minutes, and
the supernatants filter sterilized and stored at -20 °C. The periplasmic Shiga toxin
samples were prepared by resuspending the cell pellets in 250 L of polymyxin B (10
mg/mL) in PBS.95 After shaking for 15 min at 37 °C, the samples were recentrifuged at
15,000 xg for 10 min, and the supernatant (containing the periplasmic proteins) was
removed, filter sterilized, and stored at -20 °C until assayed.
Vero cells were cultured in DMEM supplemented with 5% FBS, penicillin (100
U/mg) and streptomycin (100 g/mL) at 37 °C in 5% CO2 atmosphere. For cytotoxicity
assays, Vero cells were seeded into 96-well plates at a cell density of 1 x 105 cells per
well 24 hr prior to exposure to toxin. The media in each well was then replaced with 160
µL antibiotic-free DMEM and 40 L of supernatant or periplasmic extract. All samples
were tested in replicates of five. A positive control consisted of Vero cells exposed to 40
L of ethanol. Negative controls (for cytotoxicity) consisted of untreated Vero cells,
Vero cells treated with 40 L of sterile DMMG, or Vero cells exposed to 40 L of
polymyxin B (10 mg/mL) in PBS. The plate was incubated for 48 hr at 37 °C in 5% CO2
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atmosphere. The media was then removed, and cells stained for 30 min with 100 L of
0.4% crystal violet in methanol. Excess dye was removed by rinsing the plate three times
with distilled water. Bound dye was solubilized in ethanol:acetone (80:20) solution for 15
min and the absorbance at 590 nm quantified using a BioTek Synergy HT plate reader.
The percent cytotoxicity was calculated using the equation:
(

)

where ODs is the difference in optical density at 590 nm between the sample and the
negative controls, and ODt is the difference in optical density at 620 nm between the
ethanol positive control and negative controls.
Type III Secretion System Protein Assay
The ability of WT, MTN KO, and MTN KI strains to secrete the type III secretion
system proteins EspB and Tir was measured by the enzyme-linked immunoabsorbent
assay (ELISA).64 Briefly, bacterial cultures were grown overnight in 10 mL M-9 minimal
medium supplemented with 44 mM NaHCO2, 8 mM MgSO4, 0.4% glucose, and 0.1%
casamino acids at 37 °C in 5% CO2 atmosphere.64 Cell culture supernatants were
collected by centrifugation (10,000 x g/10 min) and concentrated 100-fold by
ultrafiltration (Amicon Ultra 3K) according to the manufacturers specification. Samples
were stored at -20 °C until assayed.
ELISA plates were coated with 100 L concentrated cell culture supernatant in
binding buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM
MnCl2,) overnight at 4 °C. Wells were washed twice with PBS and blocked with 0.5%
BSA in PBS for 1 hr at 37°C. EspB or Tir proteins were detected using monoclonal antiEspB or anti-Tir antibodies (kind gift of Dr. Brett Finlay at the University of British
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Columbia) diluted 1:1000 in PBS + 0.05% Tween 20. After 1 hr in primary antibody, the
ELISA plates were washed three times with PBS and incubated for an additional 1 hr
with a horseradish peroxidase-conjugated goat anti-mouse IgG secondary antibody
(Thermo Fisher Scientific) diluted 1:1000 in PBS + 0.05% BSA. Plates were washed
three times with PBS and developed using horseradish peroxidase substrate (0.2 mg ophenylene diamine in an 50 mL 80 mM citrate–phosphate buffer, pH 5.0). Absorbance
readings (490 nm) were collected for 30 min using a Biotek Synergy HT plate reader.
Hemolysin Assays
The amount of hemolysin produced by the WT, MTN KO and MTN KI strains
was determined using a sheep red blood cell (SRBC) lysis assay.91 Briefly, bacterial
cultures and cell culture supernatants were prepared as described above for secreted
Shiga toxin. Serial dilutions of the cell culture supernatants were prepared in PBS and
100 L added to triplicate wells in a 96-well plate containing an equal volume of 3%
SRBCs in PBS. The positive and negative controls consisted of SRBC lysis buffer (150
mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA), and PBS, respectively. Plates were
incubated at 37°C with shaking for 30 min. Absorbance readings at 620 nm were
collected in a BioTek Synergy HT plate reader. Hemolysin activity was calculated using
the following equation:
(

)

where ODs is the difference in optical density at 620 nm between the sample and the
SRBC lysis buffer positive control, and ODt is the difference in optical density at 620 nm
between the PBS negative control and RBC lysis buffer positive control.
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Metabolic Enzyme Analysis
To analyze the effect of MTN deficiency on enzyme activities in central carbon
metabolism, fresh 5 mL overnight cultures of the nonpathogenic E. coli RK4353 WT,
MTN KO, and MTN KI strains were grown in DMMG at 37 °C with shaking. Overnight
cultures were diluted into 500 mL of fresh DMMG for a total of six cultures per strain
and incubated at 37 °C with shaking. The cultures were monitored
spectrophotometrically until the absorbance at 600 nm reached 0.5 (mid-log phase). At
this point, three 500 mL cultures from each strain were centrifuged at 5000 xg for 10 min
to pellet the cells. The supernatant was removed and the cell pellet was stored at -80 ºC.
The remaining three cultures of each strain were cultured for 4 hours after reaching an
absorbance (600 nm) of ~1.0 (stationary phase) and the cell pellets recovered by
centrifugation at 5000 xg for 10 min. Cell pellets were extracted by vortexing in 5 mLs of
B-PER bacterial protein extraction reagent (Pierce) for 15 minutes, and insoluble debris
removed by centrifugation at 15,000 x g for 15 min. Lysate supernatants were removed
and the protein concentration determined using a BioRad assay as described by the
manufacturer Pyruvate dehydrogenase (PDH), lactate dehydrogenase (LDH), alcohol
dehydrogenase (ADH), glutamate dehydrogenase (GDH), and  ketoglutarate
dehydrogenase (KDH) activities in mid-log and stationary phase enzyme samples from
the RK4353 WT, KO, and KI strains were measured using a colorimetric coupled assay
and following the absorbance change at 570 nm.96 Enzyme reactions were assembled in a
96-well plate, with each well containing 20 µL of a detection reagent (1 mM MTT, 150
mM NAD+, 50 µM PES) and 170 µL of a substrate buffer (500 mM KPhos, pH 8.0, 10

41
mM MgCl2, 3 mM DTT) that contained either 50mM pyruvate, 1mM CoA (for PDHC);
50 mM lactic acid (for LDH); 50 mM ethanol (for ADH); 50 mM glutamate (for GDH);
or 50 mM α-ketoglutarate, 1 mM CoA (for KDH). Enzyme reactions were initiated by the
addition of 10 µL of lysate. The increase in absorbance at 570 nm was measured every 30
sec for 30 min using a BioTek Synergy HT plate reader. Average specific activities were
calculated using the Beer-Lambert law (A=lc) using an extinction coefficient of 13 mM1

cm-1. All reactions were run at least three times. The results were expressed in U/mg,

where 1 U = 1 mol NADH created per min of mg of lysate protein.
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CHAPTER FOUR: RESULTS AND DISCUSION
Creation and Analysis of a Genetic MTN Knock-out in E. coli O157:H7
Creation of the MTN gene knock-out strain of E. coli O157:H7 was achieved
using the λ-red recombination system. The coding region for pfs (MTN) was replaced
with a chloramphenicol resistance cassette (Figure 17). Successful transformation was
difficult to obtain. Multiple attempts (> 10) to create the MTN KO failed. Probably this
was due to the severe effect on growth caused by the MTN deletion. Eventually, an
experiment resulted in two very small colonies surviving selection on chloramphenicol
plates. Both colonies were repeatedly propagated under chloramphenicol selection to
ensure gene deletion. Gene deletion was further confirmed by PCR (data not shown). The
creation of a MTN knock-in strain was achieved by transforming the pMTN plasmid into
MTN KO cells and selecting for ampicillin resistance. The resulting KI strain was MTN+
Cmr Ampr, and expressed MTN under the control of an IPTG inducible promoter.
To ensure that the MTN KO strain had completely lost the ability to produce
MTN, western blot and nucleosidase assays were performed (Figure 17). A monoclonal
α-MTN antibody readily detected the 24.5 KD nucleosidase in western blots of cell
lysates of the WT and MTN KI strains, but not in lysates of the MTN KO strain (Figure
17 B). Similarly, MTA nucleosidase activity was detected in lysates of the WT and MTN
KI strains. The MTN KO strain showed significant loss of nucleosidase activity relative
to the WT strain (p<0.05). The residual enzyme activity in the MTN KO strain was at the
limit of detection in the assay (Figure 17 C). While theoretically no MTN activity should
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be present in the MTN KO strain, the small amount of substrate conversion in the assay
could be due to solvent hydrolysis or the activity of nonspecific nucleosidases present in
the lysate (e.g., AMP nucleosidase or purine nucleoside phosphorylase).
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Figure 17. Analysis of the E. coli O157:H7 MTN knock-out strain. (A) Representation
of the dgt-pfs-butF-yadS region of the E. coli O157:H7 chromosome map. The Δpfs:Cm
knockout strain was created by a 599 bp in-frame deletion of the pfs gene and insertion of
the 1034 bp Cmr cassette. (B) Western blot analysis of MTN in WT, MTN KO, and MTn
KI strains. MTN in cell lysates (20 μg protein/lane) was detected using a monoclonal
mouse α-MTN antibody followed by staining with a goat α-mouse Ig-HRP conjugate.
(C) Specific activities of cell lysates (40 μg protein /assay) were analyzed by UV enzyme
assay (275 nm) using 100 μM MTA substrate. (1 U = 1 μmol/minute, n = 3, ± SEM) *
denotes p<0.05 by 1way ANOVA.

44
Effect of MTN Deficiency on Growth
MTN deficiency severely decreased growth rates in the MTN KO strain. This was
initially evident in the small colony size of the MTN KO strain, and intermittent
difficulty in growing overnight stock cultures in minimal media. In 96-well plate growth
assays, an 18 hour delay in achieving mid-logarithmic phase growth was typically
observed for the KO strain when compared to the WT (Figure 18 A). However, the MTN
KO strain did eventually reach the same cell density as the WT culture. The MTN KI
strain growth closely matched the WT strain. This indicates that the growth delay in the
MTN KO strain can be attributed to the loss of MTN activity.
Similar growth defects have been observed in other MTN KO strains constructed
in the nonpathogenic E. coli RK435368 and Neisseria meningitidis.43 In the initial report
on the E. coli RK4353 MTN KO strain, investigators found a very strong reduction in
growth in minimal media supplemented with methionine, and no growth in the absence of
supplementation. These authors also reported that growth was restored in the MTN KO
strain when it was transformed with a plasmid containing MTN.68 This finding is similar
to the results we show in Figure 18 A (KI black dashed line). The Neisseria meningitidis
MTN KO strain also showed similar growth deficiencies, even in nutrient rich medium.
Growth was restored in the Neisseria MTN KO strain when the MTN gene was
reintroduced on a plasmid.43
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Figure 18. Comparison of growth of E. coli O157:H7 WT, MTN KO and MTN KI in
Davis minimal media (A). Media was also supplemented with lipoate (B), thiamine,
(C), biotin (D), DPD (E) and a mix of all the previous (F). Data shown is the average of
three experiments with n = 3 replicates.
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How loss of MTN activity caused growth delay in E. coli O157:H7 was probed by
the addition of various vitamin supplements to the culture medium. Since MTN
deficiency could result in an increase in 5‟dADO concentration that would subsequently
cause feedback inhibition of radical SAM reactions involved in vitamin synthesis10,82, the
effect of lipoate, thiamine and biotin supplementation on cell growth was explored
(Figure 18 B, C, D). Of the three vitamins, lipoate supplementation showed the greatest
effect on MTN KO strain growth. When MTN KO strain cultures were supplemented
with 1 µM or 100 µM lipoate (Figure 18 B, gray dashed lines), the growth rate was
dramatically improved and the time to achieve mid-log phase growth was shifted to
within roughly 6 hours of the WT culture. Thiamine supplementation (1 µM or 100 µM)
showed a less extreme effect on MTN KO strain growth with mid-log phase achieved at
approximately 25 hours, or within 12 hours of WT growth (Figure 18 C, gray dashed
lines). Lastly, biotin supplementation (1 µM or 100 µM) had the least effect on vitamin
stimulated growth recovery in the MTN KO strain. Biotin supplemented cultures reached
mid-log phase only 8 hours sooner than the unsupplemented MTN KO culture (Figure 18
D, gray dashed lines).
MTN gene deletion disrupts the primary pathway to AI-2 production by
preventing hydrolysis of SAH to S-ribosylhomocysteine (SRH) that would block
subsequent luxS mediated synthesis of DPD. While a second potential path to DPD
synthesis has been reported, it was not found to be a significant source of AI-2 in E.
coli.81 In addition, prior work in Neisseria and a nonpathogenic E. coli strain (RK4353)
showed that MTN gene deletion abolished AI-2 production.43,71 To examine the potential
role of AI-2 on E. coli O157:H7 growth, cultures of WT and MTN KO strains were
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supplemented with DPD, the precursor to AI-2. DPD did not appear to improve growth
rates in either the WT or MTN KO strain (Figure 18 E). These results are similar to those
reported for N. meningitidis,43 and support the assertion that the observed growth defects
are not autoinducer-2 dependent.
In summary, the defects in planktonic cell growth due to MTN deficiency could
largely be attributed to inhibition of radical SAM reactions that resulted in decreased
LipA, BioB, and ThiH synthesis of lipoate, biotin and thiamine, respectively.10 However,
culture supplementation with a mixture of all three vitamins and DPD failed to
completely restore growth, suggesting that other deficiencies were also present in the
MTN KO strain (Figure 18 F). Overall, the results of these growth studies suggest that
MTN inhibitors could exert their antibiotic effect due to interruption of radical SAM
reactions because of feedback inhibition by 5‟dADO. In addition, the observation that the
MTN KO strain did eventually reach a culture density similar to the WT strain suggests
that MTN inhibitors will behave in a bacteriostatic rather than bactericidal manner.
Effects of MTN Deficiency on Biofilms
When biofilm production was examined in a polystyrene-tube growth assay,
obvious culture differences were observed by crystal violet staining (Figure 19 A). The
WT strain showed heavy biofilm growth, particularly at the liquid-air interface. The
MTN KO strain showed little crystal violet staining. Culture supplementation with DPD
failed to restore biofilm growth. Similar to the planktonic growth studies, vitamin
supplementation (100 µM lipoate, thiamine, biotin) restored MTN KO biofilms to
approximately WT levels. The reduction in biofilm due to MTN KO was further
quantified in a 96-well plate assay. Wells containing 48 hour cultures of WT and MTN
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KO cells (+/- supplementation) were stained with crystal violet and the biofilms
quantified by measuring the spectrophotometric absorbance at 595 nm. The results
showed that biofilms were reduced by greater than 80% in the MTN KO strain when
compared to the WT strain (Figure 19 B). Again, vitamin supplementation restored MTN
KO biofilms, whereas the addition of DPD did not.
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Figure 19. Comparison of biofilm production by E. coli O157:H7 WT and
MTN KO strains. (A) Crystal violet staining in 48 hour biofilms grown in minimal
media. MTN KO cultures were supplemented with 25 µM DPD, 100 µM vitamin
mix (Vit), or DPD and vitamin mix (DPD + Vit). (B) Quantitative data of crystal
violet stained biofilms (± SEM, n = 3).* denotes p < 0.05 by One-way ANOVA
The effect of MTN KO on E. coli O157:H7 biofilm formation was also examined
by confocal microscopy (Figure 20). In these studies, biofilms were grown directly on
plastic cover slips and visualized by staining with acridine orange. As the figure shows,
the WT and MTN KI strains formed heavy biofilms (Figure 20 A). By comparison, the
MTN KO strain formed only a weak disperse biofilm. Three dimensional pictures created
from serial images through the depth of the biofilm further show the mature architecture
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of the WT and MTN KI strain biofilms (Figure 20 B). Biofilm formation in the MTN KO
was too weak to assemble a three dimensional image.
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Figure 20. Confocal microscopy of biofilms produced by E. coli O157:H7 WT, MTN
KO, and MTN KI strains. Biofilms were grown for 48 hours on plastic coverslips and
stained with acridine orange. (A) Images taken at 630x magnification. (B) 3-D images
created from Z-stacks at 630x magnification. Biofilms were insufficient in the MTN KO
strain to create a 3-D image.
Previous work has demonstrated the disruption of E. coli O157:H7 biofilms using
MTN inhibitors.71 However, biofilm formation was only reduced by 18% when compared
to the untreated control. Potentially this modest effect on biofilms could be attributed to
poor drug permeability into the E. coli cells. On the other hand, the same drug treatment
caused a 70% reduction in Vibrio cholera biofilms.71 Overall, our studies indicate that
biofilm formation in E. coli O157:H7 is dependent on the availability of vitamins used by
metabolic enzymes, rather than AI-2 signaling. In this regard, the reports in the literature
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of the effects of AI-2 on biofilm formation are not consistent. For the majority of these
studies, luxS KO strains were examined since they are unable to make DPD, the precursor
to AI-2. 72-75 The loss of biofilm formation seen in the luxS KO strains was attributed to
lack of AI-2 signaling, but nutrient supplementation was not investigated. In one study,
supplementation of WT E. coli O157:H7 with DPD increased biofilm formation by 30fold.72 In our studies, DPD treatment did not cause an increase in WT biofilms (not
shown). However, the abundant biofilms formed by the WT strain we studied may have
masked any overt influence by DPD, and we did not examine early stages of biofilm
formation.
Effect of MTN Deficiency on Virulence Factors
Adherence
The effect of MTN deficiency on virulence was initially examined by comparing
the ability of the WT and MTN KO strains to adhere to mammalian cells. Cows are the
main reservoirs for E. coli O157:H7, thus the ability of the bacteria to adhere to cultured
bovine epithelial cells was measured. Using confocal microscopy, the adherence of the
WT strain to the surface of bovine Mac-T cells was readily apparent (Figure 21 A). To
find adherent MTN KO cells was difficult, as these events were visible on fewer than 1 in
50 microscopic fields (Figure 21 B).
Microbial adherence was also measured by counting colony forming units (CFUs)
after bacteria were incubated with bovine Mac-T cell cultures. In these experiments,
bacterial cells were added to the mammalian cell culture at an MOI of ~100. Adhered
bacterial cells were liberated following detergent lysis of the mammalian cell culture and
enumerated by counting the colonies that appeared on LB agar plates. As the graph in
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Figure 14 C shows, the MTN KO strain exhibited an 85% decrease in adherence to
bovine Mac-T cells relative to the WT strain. Similar results were obtained when the
experiment was performed with the human HeLa cell line (not shown). There are no
other reports of adherence studies using MTN KO strains. However, the adherence and
infectivity of luxS mutants has been studied.43,77 Epithelial cell adherence was reported to
be reduced by two orders of magnitude in a luxS mutant strain of enteropathogenic E. coli
(EPEC).77 In the pathogen N. meningitidis, luxS mutants were attenuated for the ability to
cause bacteremia in mice.43 These studies established that loss of AI-2 synthesis
decreased bacterial virulence. They suggest that interruption of MTN activity could
similarly be expected to reduce virulence since AI-2 is also not made in the MTN KO
strain.
Since nutrient supplementation caused profound effects on bacterial growth and
biofilm production, the effect of similar supplementation was studied in the mammalian
cell adherence assay. Overnight culture of the bacterial cells with either DPD (25 µM),
vitamin mix (100 µM each lipoate, thiamine, biotin), or both (DPD + Vit) failed to
improve adherence of the MTN KO strain to Mac-T cells (Figure 21 C). This data
indicates that adherence is not due to AI-2 signaling or vitamin dependent metabolism.
Other studies suggest that E. coli O157:H7 adherence is influenced by AI-3 rather than
AI-2 signaling.67 In general, the conflicting reports of the effect of AI-2 signaling on
bacterial adherence and virulence underscores the complexity of these processes. The
failure of culture supplementation with DPD and vitamins to reverse the loss of
adherence to mammalian cells by the MTN KO strain suggests that other factors (e.g.,
specific methylations, polyamines, etc.) are required for this event.
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Figure 21. Analysis of E. coli O157:H7 WT and MTN KO strain adherence to
bovine Mac-T cells. Confocal microscopy images of WT (A) and MTN KO (B)
adherence to Mac-T cells. Bacteria were stained for nucleic acid (green). Mac-T cells
were stained for actin (red) and nuclei (green). Bacterial adherence to Mac-T cells
were determined as the CFU recovery compared to WT 3 hours post infection. MTN
KO cultures were supplemented during growth with DPD, vitamin mix, or DPD and
vitamin mix (* denotes p <0.05 when compared to WT, ± SEM, n = 3)
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Shiga Toxin
One of the most deadly aspects of an E. coli O157:H7 infection is the high risk of
developing HUS due to Shiga toxin-mediated damage to kidney endothelial cells. To
better understand how MTN inhibitors may influence this type of virulence, the
production of Shiga toxins in WT and MTN KO strains were compared using an African
green monkey kidney epithelial (Vero) cell assay. Shiga toxin 1 (Stx1) is primarily found
in the periplasmic space, whereas Shiga toxin 2 (Stx2) is secreted into the media.70 Shiga
toxin levels in cell culture supernatants and periplasmic extracts were compared for each
strain. A significant decrease in cytotoxicity (~60%) was observed for culture
supernatants derived from the MTN KO strain when compared to the WT strain (Figure
22 A). Culture supplementation with DPD (25 µM) alone was insufficient to reverse the
loss of cytotoxicity. When the MTN KO strain culture was supplemented with either
vitamin mix (100 µM each lipoate, thiamine, biotin) or DPD and vitamin mix (DPD +
Vit), Shiga toxin mediated cytotoxicity was restored to WT levels. No significant
difference was seen for Vero cell cytotoxicity in the periplasmic extracts from each strain
(Figure 22 B). To ensure that differences in cytotoxicity in the assay were not masked by
saturating levels of toxin, the assay was performed using a series of periplasmic extract
dilutions. In general, the MTN KO strain retained more Shiga toxin activity in the
periplasm than the WT strain (Figure 22 C). Culture supplementation did not result in
more Shiga toxin release from the periplasm. Our results show that the MTN KO strain is
still producing both Stx1 and Stx2. The increased level of periplasmic Stx in the MTN
KO strain could be the result of increased expression of Stx-1 or decreased secretion of
Stx-2. The effect of MTN interruption on Stx expression appears to be connected to the
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nutrient status of the cells, rather than AI-2 signaling. Overall, our results suggest that
MTN inhibitors could exert their antibiotic effect through decreased Shiga toxin release
as one mechanism of action.
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Figure 22. Effect of MTN deficiency on Shiga toxin production in E. coli O157:H7.
Comparison of Vero cell cytotoxicity when treated with (A) culture supernatants and (B)
periplasmic extracts of WT and MTN KO strains. Cultures were supplemented during
growth with DPD, vitamin mix, or DPD and vitamin mix. (C) Vero cell cytotoxicity
measurements using a dilution series of periplasmic extract. (* denotes p <0.05 when
compared to WT, ± SEM, n = 3).
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There have been no prior reports of Stx production in MTN KO strains. However,
a luxS deficient strain of E. coli O157:H7 was reported to secrete approximately two-fold
less Stx.85 Despite this, the virulence of the strain in mice was not altered. Similarly, a
luxS mutant of Clostridium perfringens produced reduced amounts of alpha-, kappa-,
theta-toxins when compared to the WT strain.78 Unfortunately, in these reports, the effect
of AI-2 or nutrient supplementation was not explored so it is difficult to assess if the
results were due to loss of AI-2 signaling or nutrient salvage. In any case, luxS deficiency
would not result in the same accumulation of inhibitory nucleosides like the MTN KO
strain. Thus, the effects of luxS deficiency do not necessarily predict the same responses
that would be encountered with loss of MTN activity.
Type III Secretion System Proteins
E. coli O157:H7 produces a multitude of other virulence factors that contribute to
its pathogenicity. The LEE pathogenicity island encodes many of these virulence factors,
including those that are required to assemble the type III secretory system (TTSS).76
Secretion of two specific TTSS proteins, EspB and Tir, by WT, MTN KO and MTN KI
strains was analyzed by ELISA (Figure 23 A, B). EspB is a major constituent of the
TTSS pore, while Tir is translocated through the pore into the host cell where it mediates
subsequent bacterial adherence and pedestal formation. The MTN KO strain showed a
significant decrease (20%) in EspB secretion when compared to the WT strain. EspB
production was recovered to WT levels in the MTN KI strain. No significant difference
was seen for the secretion of Tir. The decreased production of EspB in the MTN KO
strain could result in decreased pore formation that would reduce Tir delivery to the host
cell. This could be responsible for the decreased host cell adherence displayed by the
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MTN KO strain (Figure 23). However, the modest decrease in EspB is likely not
sufficient to account for all of the loss in adherence shown by the MTN KO strain. The
TTSS contains numerous other proteins required for host cell adherence. A
comprehensive investigation of the entire system is required before the effect of MTN
deficiency on TTSS can be fully understood.
The TTSS has not been previously studied in MTN KO strains. The effects on
TTSS proteins have been studied extensively in luxS mutants of E. coli
O157:H7.66,76,78,79,80,83 In these studies, LEE transcription was decreased in the luxS
mutants. Similar to our observations on the MTN KO strain, the luxS mutants showed a
minimal ability to adhere to mammalian cells.76 Western blot analysis of the luxS mutants
revealed decreased expression of TTSS proteins, including EspA, EspB, and Tir
responsible for the loss of mammalian cell adherence.66,76,78 It is unclear why there are
differences in expression of Tir between the MTN KO and luxS mutant strains. However,
the results suggest that additional factors beyond AI-2 signaling are involved in gene
expression from the LEE.
Hemolysin
The final virulence factor that was investigated in this study was hemolysin. The
function of hemolysin is to lyse red blood cells, which allows the bacteria to harvest the
liberated iron. Hemolysin secretion by WT, MTN KO, and MTN KI strains was
measured by examining the ability of cell culture supernatants to lyse sheep red blood
cells. The results are expressed as a percentage of the control detergent lysis (100%
control). The MTN KO strain showed a significant decrease (33%) in hemolysin activity
relative to the WT and MTN KI strains (Figure 23 C). A similar finding was reported in a
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luxS mutant strain of Serratia marcescens, where production of secreted hemolysin was
reduced when compared to the WT strain. In addition, the investigators were able to fully
restore hemolysin production by expression of luxS in trans.73
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Figure 23. Comparison of virulence factor production in E. coli O157:H7 WT, MTN
KO, and MTN KI strains. (A) ELISA analysis of secreted EspB. (B) ELISA analysis of
secreted Tir. (C) Analysis of secreted hemolysin activity. (* denotes p <0.05 by one-way
ANOVA, ± SEM, n = 3).
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Overall, the MTN KO strain showed a significant decrease in virulence when
compared to the parental WT strain. This provides support to the hypothesis that MTN
inhibitors could act as to regulate virulence rather than directly kill bacterial cells. In
reducing the ability of the pathogen to produce virulence factors, MTN inhibitors could
improve the ability of the host immune system to clear infections.
Metabolic and Proteomic Analysis of E. coli RK4353
Prior work in our lab used nuclear magnetic resonance to examine the profiles of
excreted metabolites in cell culture supernatants of the nonpathogenic E. coli RK4353
WT, MTN KO, and MTN KI strains. Metabolite differences were observed at mid-log
and stationary phases of growth. The most notable differences were the accumulation of
pyruvate (4.8 mM), lactate (0.5 mM) and glutamate (3.6 mM) in the culture supernatants
of the MTN KO strain, while these compounds are scarcely detectible (<0.1 mM) in the
WT and MTN KI strains. In addition, the WT and MTN KI strain cultures accumulated
ethanol (0.4-0.5 mM) and acetate (4-5 mM), which are both products of vitamin
(thiamine, lipoate) dependent fermentation of pyruvate. The MTN KO strain did not
accumulate these compounds to the same degree (<0.1 mM ethanol; 2 mM acetate).
These results suggested that there are defects in vitamin dependent central carbon
metabolism in the MTN KO strain. Specifically, the pyruvate dehydrogenase complex
(PDHC, lipoate-, thiamine-dependent) at the end of glycolysis and the -ketoglutarate
dehydrogenase complex (-KDHC, lipoate-, thiamine-dependent) in the tricarboxylic
acid cycle both appear to be attenuated in their activity. Thus, pyruvate accumulates in
the MTN KO strain culture, or is converted through the non-vitamin dependent lactate
dehydrogenase (LDH) to yield lactate. Reduced metabolic flux through -KDHC would
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lead to -ketoglutarate being converted to 2-oxoglutarate and finally to glutamate
through the non-vitamin dependent glutamate dehydrogenase pathway. The results of
these studies served as the basis for our hypothesis that altered metabolism in the MTN
KO strain is attributable to decreased radical SAM dependent vitamin synthesis. Since
central carbon metabolism ultimately controls the ability to produce energy through
oxidative phosphorylation, altered metabolism would impact growth.
Cell culture supernatants of the MTN KO strain also accumulated MTA (3-6M),
indicating that the nucleoside was getting secreted as a mechanism to prevent
intracellular accumulation of this growth inhibitory nucleoside. As expected, MTA was
absent from the WT and MTN KI strain culture supernatants, since the nucleosidase
would function to efficiently catabolize the compound in these strains.
Proteomic analysis of the three nonpathogenic E. coli strains (WT, MTN KO, and
MTN KI) was conducted at Pacific Northwest National Labs using Liquid
Chromatography-Tandem Mass Spectrometry (LCMS). While not directly part of the
thesis work, some of the results are presented here since they provide the rationale to
support our subsequent comparison of enzyme activities in the WT, MTN KO, and MTN
KI strains. The results of proteomic analysis are presented in Table 4. The MTN KO
strain appears to express more PDHC and LDH proteins than the WT strain. The WT
strain produced more -KDHC and glutamate dehydrogenase than the MTN KO strain.
However, a direct correlation between the protein expression and the results of the NMR
analysis was not supported. It is possible that the vitamin dependent enzymes were
overexpressed in the MTN KO strain, but not functionally active due to decreased
vitamin synthesis in this strain.
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To further investigate the results of the metabolic and proteomic experiments,
multiple enzyme assays were performed. The PDHC specific activity of the cell lysate
supernatants from the MTN KO strain was greatly diminished when compared to the WT
strain (Figure 24 A). This would explain the accumulation of pyruvate in the MTN KO
cell culture supernatants. When enzyme assays containing MTN KO cell lysates were
supplemented with lipoate and thiamine, the PDHC activity was fully recovered. This
supports our earlier findings that radical SAM-dependent vitamin synthesis was deficient
in the MTN KO strain. Theoretically, the same situation should arise in α-KDHC as in
PDHC, but we were unable to detect α-KDHC activity.
Table 4. Proteomic Differences in the WT and KO strains of E. coli RK4353
Protein Identification and Purpose
ADH-Alcohol Dehydrogenase

Fold Change*
Mid-Log

p-value
Stationary

Mid- Log

Stationary

mhpF [acetaldehyde-CoA dehydrogenase II]

-3.8

-2.7

0.013

0.012

adhE [acetaldehyde: alcohol dehydrogenase]

1.1

1.3

0.642

0.337

PDHC-Pyruvate Dehydrogenase Complex
aceE [pyruvate dehydrogenase, decarboxylase
component E1]
aceF [pyruvate dehydrogenase, dihydrolipoyltransacetylase
c
component E2]

-1.8

-1.7

0.054

0.061

-2

-1.9

0.022

0.037

lpd [lipoamide dehydrogenase]

-1.6

-1.7

0.004

0.023

-3.3

-3.4

0.05

0.291

1.4

-1.2

0.045

0.608

1.2

1.2

0.478

0.565

LDH- Lactate Dehydrogenase
ldhA [fermentative D-lactate dehydrogenase]
αKDHC-α-Ketoglutarate Dehydrogenase Complex
sucB [dihydrolipoyltranssuccinase\ subunit of α-ketoglutarate
DH]
GDH-Glutamate Dehydrogenase
gdhA [glutamate dehydrogenase]

* Negative values denote expression is higher in the KO strain than in the WT strain. Positive values denote
a lower expression in the KO strain than the WT strain.

The MTN KO strain appears to adapt to decreased PDHC and α-KDHC by
directing pyruvate and α-ketoglutarate down alternate metabolic paths. Pyruvate
conversion to lactate is increased since LDH activity does not require vitamins. However,
the increased flux through LDH did not require additional enzyme activity (Figure 17 B).
Similarly, glutamate production was increased in the MTN KO strain, but increased GDH
activity was not seen (Figure 24 D).
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Lastly, while ethanol excretion was increased in the WT strain, this was not the
result of increased ADH expression (Figure 24 C). Probably, the increased metabolic flux
through ADH was the result of increased vitamin dependent pyruvate decarboxylase in
the WT strain that subsequently increased the concentration of acetaldehyde substrate for
ADH. In summary, the results of our analyses of metabolic enzymes indicate that loss of
radical SAM-dependent vitamin synthesis plays a major role in metabolic adaptations in

A
Specific Activity (U/mg)
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Figure 24. Analyses of the specific activities of enzymes affected by MTN deficiency in
E. coli RK3453. (A) Pyruvate dehydrogenase complex, (B) lactate dehydrogenase, (C)
alcohol dehydrogenase and (D) glutamate dehydrogenase specific activities were measured
by a colorimetric assay using cell lysates from the WT, MTN KO, MTN KI strains. The
specific activity of the KO strain was supplemented with lipoate and thiamine was also
measured for the pyruvate dehydrogenase complex. (* denotes p <0.05 when compared to
WT, ± SEM, n = 3)
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Future Work
The work following this thesis will consist of metabolomic and proteomic
analyses of the WT and MTN KO strains of E. coli O157:H7. Initial studies will compare
this pathogenic strain to the data obtained from the nonpathogenic RK4353 strain.
Analysis of various virulence factors will also be performed. Another goal is to discover
other adaptations to MTN deficiency that can be identified as drug targets. The WT and
KO strain of E. coli O157:H7 will be subjected to an array of enzyme assays to further
support data found in the proteomic studies. In tandem with the LCMS analysis of
virulence factors, real-time PCR investigations will be performed to understand MTN
deficiency on mRNA expression. This will ultimately provide a complete understanding
of MTN deficiency in a pathogenic strain of bacteria and serve as a standard comparison
for MTN inhibitors.
Once the profile of MTN deficiency is established, the work will shift to testing
various MTN inhibitors against the WT E. coli O157:H7 strain and on other bacterial
species. In addition to sole inhibitor analysis, co-treatment studies with traditional
antibiotics and MTN inhibitors will be performed to examine potential drug synergy.
Various bacterial species that have developed resistance to most antibiotics, such as
MRSA, will be treated with MTN inhibitors to determine if drug resistance can be
reversed. The ultimate goal will be to test MTN inhibitors as antibiotics to treat infections
in mammals (i.e., mice). This testing would provide the results needed to further pursue
MTN inhibitors as antibiotic treatments in humans.
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CHAPTER FOUR: CONCLUSION
Antibiotic resistance is a serious problem and eventually all forms of bacteria may
become resistant to traditional antibiotics, thus making every infection potentially deadly.
Due to this threat, there is a dire need for novel forms of antibiotics. A promising
antibiotic target is the bacterial-specific MTN enzyme. Loss of this critical enzyme in a
MTN KO strain of the pathogenic E. coli O157:H7 has been shown in this work to result
in a significant delay in growth and reduce multiple aspects of virulence. Specifically,
adherence to bovine epithelial cells was reduced by over 85% compared to the WT strain.
The MTN KO strain also displayed a 60% reduction in Shiga toxin mediated cytotoxicity.
Furthermore, the reduction in adherence could be partially attributed to the diminished
production of TTSS proteins, in particular EspB.
Supplementation studies with DPD indicated that the alterations to growth and
virulence were not due to loss of AI-2 signaling. When the MTN KO strain culture was
supplemented with vitamins (lipoate, thiamine, and biotin) growth and biofilm formation
was partially restored to WT levels. This suggests that the antibiotic mechanism of action
for MTN inhibitors partially occurs through altered central carbon metabolism or
decreases in other vitamin dependent enzyme activity. Further metabolomic and
proteomic investigation of a nonpathogenic E. coli RK4353 strain revealed adaptations to
MTN deficiency. Specific analyses of enzymes key to central carbon metabolism found
an overproduction of a defective PDHC, whereas specific activity for LDH, ADH, and
GDH were unchanged. The activity of the defective PDHC was restored with the addition
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of lipoate and thiamine, further supporting that MTN deficiency disrupts vitamin
synthesis. This study as a whole serves as the foundation for future investigations of
MTN inhibitors as potential antibiotics.
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